arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

Lifevantage Corp

LFVN
$6.16 ▼ -0.08 (-1.28%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
65 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Neutral
auto_awesome

Analytical Summary

Lifevantage Corp shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth -23.1%
Op. Margin 3.9%
ROIC 3.7%
FCF / Share None
Trailing P/E 61.6x
Price / Book 2.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

65-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$42.38M
↓ -23.1%
Net Income Profit after all expenses
$1.28M
↓ -34.7%
Operating Margin Operating profit as % of sales
3.9%
↑ +2.5% 38th
FCF / Share Free cash flow per share
$0.32
↑ +133.3%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%

Health Breakdown

Profitability
37
Returns
71
Financial Health
98
Cash Quality
74

Dividend History

Dividend / share · sourced from SEC filings
$0.18 Latest / share
+12.1% YoY
+57.6% 5-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 65 quarters